StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns

计划入组 13 人 · 首次发布于 2021 年 2 月 21 日

Moderna TX

计划入组 500 人

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

计划入组 12 人 · 首次发布于 2021 年 2 月 17 日

TX-2100

TX-45(Tectonic Therapeutic)

TX-153

Bicycle Tx Limited

Shield TX (UK) Ltd.

United Kingdom

PLL TX AUSTRALIA PTY LTD

Australia

Telix Opens Australia's First Integrated Radiopharmaceutical Facility to Accelerate Cancer Theranostics

FDA Approves Telix's Pixclara, First FET-PET Imaging Drug for Glioma in the U.S.

FDA Issues Complete Response Letter for Telix's Kidney Cancer Imaging Agent TLX250-CDx